THE BROOK HEALTH CENTRE — All Prescriptions & Medications — Page 6
Practice Code: K83620 | TOWCESTER, NN12 6HD
Showing results 251-300 of 558
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Sotalol hydrochloride | 75 | 3,920 | £132 | +6.7% ▲ |
| Rivastigmine | 75 | 3,340 | £894 | +9.0% ▲ |
| Diclofenac sodium | 75 | 3,800 | £2.7K | +212.9% ▲ |
| Diphtheria | 75 | 75 | £520 | +12.4% ▲ |
| 75 | 75 | £322 | +46.2% ▲ | |
| 75 | 36.0K | £529 | -71.6% ▼ | |
| Tamoxifen citrate | 74 | 1,908 | £160 | -10.1% ▼ |
| Dexamethasone | 73 | 755 | £215 | +22.3% ▲ |
| Ursodeoxycholic acid | 72 | 8,400 | £1.0K | +8.8% ▲ |
| Terbutaline sulphate | 72 | 72 | £563 | +32.8% ▲ |
| Zolmitriptan | 72 | 708 | £2.2K | +10.9% ▲ |
| Hydrocortisone acetate | 71 | 2,160 | £406 | +7.5% ▲ |
| 71 | 860 | £2.3K | +48.5% ▲ | |
| Ketone blood testing reagents | 70 | 1,130 | £1.3K | +3.4% ▲ |
| 70 | 1,930 | £714 | -9.5% ▼ | |
| Adrenaline | 69 | 169 | £9.4K | +9.4% ▲ |
| Rizatriptan | 69 | 636 | £1.3K | +16.1% ▲ |
| Methocarbamol | 69 | 8,472 | £572 | +44.2% ▲ |
| Ranolazine | 68 | 1,504 | £288 | -60.0% ▼ |
| Cinacalcet hydrochloride | 68 | 728 | £285 | +193.1% ▲ |
| Alfacalcidol | 68 | 3,360 | £578 | -45.0% ▼ |
| Triptorelin | 66 | 66 | £12.1K | +212.9% ▲ |
| Triptorelin acetate | 65 | 65 | £4.0K | +353.4% ▲ |
| 65 | 6,502 | £310 | -50.4% ▼ | |
| 65 | 226 | £1.5K | +133.6% ▲ | |
| Lithium carbonate | 64 | 2,573 | £392 | -49.6% ▼ |
| Metronidazole | 63 | 1,305 | £204 | -4.1% ▼ |
| Timolol | 63 | 1,190 | £291 | -28.8% ▼ |
| 63 | 184 | £861 | +103.1% ▲ | |
| Peppermint oil | 62 | 2,284 | £196 | -22.1% ▼ |
| Ticagrelor | 62 | 3,480 | £3.4K | -27.1% ▼ |
| Bempedoic acid/Ezetimibe | 61 | 1,708 | £3.1K | -0.1% vs avg |
| Alogliptin | 61 | 616 | £535 | -75.9% ▼ |
| Oxytetracycline | 60 | 2,073 | £729 | +132.3% ▲ |
| 60 | 6,830 | £477 | -14.0% ▼ | |
| Alogliptin/metformin | 59 | 3,304 | £1.5K | +41.4% ▲ |
| Neomycin sulfate | 59 | 900 | £112 | -0.5% vs avg |
| Valproic acid | 57 | 2,880 | £762 | -34.5% ▼ |
| Carbomer 940/980 | 57 | 1,010 | £158 | -62.6% ▼ |
| 57 | 6,740 | £739 | +18.2% ▲ | |
| Biphasic insulin aspart | 55 | 440 | £2.4K | -45.8% ▼ |
| Pizotifen malate | 54 | 1,960 | £88 | -34.5% ▼ |
| Co-careldopa (Carbidopa/levodopa) | 54 | 6,854 | £537 | -76.1% ▼ |
| Ibandronic acid | 54 | 109 | £100 | +48.6% ▲ |
| 54 | 8,476 | £332 | -88.6% ▼ | |
| 54 | 4,110 | £13.4K | +43.7% ▲ | |
| Etoricoxib | 53 | 1,484 | £378 | -34.2% ▼ |
| Colchicine | 53 | 1,362 | £28 | -32.0% ▼ |
| Powder extensively hydrolysed formula (0913101) | 52 | 131.6K | £3.6K | -27.8% ▼ |
| Dorzolamide | 52 | 1,540 | £710 | -37.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.